The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
P2X Receptors as Drug Targets
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Central sensitization: implications for the diagnosis and treatment of pain
Woolf, C. J. (2011) · Pain · doi:10.1016/j.pain.2010.09.030 · Cited by 4,771
Cellular and Molecular Mechanisms of Pain
Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009) · Cell · doi:10.1016/j.cell.2009.09.028 · Cited by 4,344
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Self-citationA STUDY OF THE ADRENOTROPIC RECEPTORS
Ahlquist, R. P. (1948) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1948.153.3.586 · Cited by 2,893
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Burnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Self-citationExtracellular ATP: effects, sources and fate
Gordon, J. L. (1986) · Biochemical Journal · doi:10.1042/bj2330309 · Cited by 1,658
Physiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,585
Identification of the platelet ADP receptor targeted by antithrombotic drugs
Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423
Is there a basis for distinguishing two types of P2-purinoceptor?
Burnstock, G., & Kennedy, C. (1985) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(85)90001-1 · Cited by 1,365
A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP
Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., & Buell, G. (1994) · Nature · doi:10.1038/371516a0 · Cited by 1,029
Self-citationThe P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor
Brake, A. J., Wagenbach, M. J., & Julius, D. (1994) · Nature · doi:10.1038/371519a0 · Cited by 919
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., & Surprenant, A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00229-1 · Cited by 863
Self-citationDisruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Chessell, I. P., Hatcher, J. P., Bountra, C., Michel, A. D., Hughes, J. P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W. L., et al. (2005) · Pain · doi:10.1016/j.pain.2005.01.002 · Cited by 789
Perregaux, D., & Gabel, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36591-2 · Cited by 758
Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans
Cully, D. F., Vassilatis, D. K., Liu, K. K., Paress, P. S., Van der Ploeg, L. H. T., Schaeffer, J. M., & Arena, J. P. (1994) · Nature · doi:10.1038/371707a0 · Cited by 756
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Kawate, T., Michel, J. C., Birdsong, W. T., & Gouaux, E. (2009) · Nature · doi:10.1038/nature08198 · Cited by 738
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Hattori, M., & Gouaux, E. (2012) · Nature · doi:10.1038/nature11010 · Cited by 551
Cloning and functional expression of a brain G‐protein‐coupled ATP receptor
Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., Burnstock, G., & Barnard, E. A. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81397-i · Cited by 548
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R., Rollema, H., & Bertrand, D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 522
Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response
Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., Brissette, W., Wicks, J. R., Audoly, L., & Gabel, C. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6436 · Cited by 490
Jarvis, M. F., Burgard, E. C., McGaraughty, S., Honore, P., Lynch, K., Brennan, T. J., Subieta, A., van Biesen, T., Cartmell, J., Bianchi, B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252537299 · Cited by 470
Self-citationHonore, P., Donnelly-Roberts, D., Namovic, M. T., Hsieh, G., Zhu, C. Z., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111559 · Cited by 414
Self-citationBrilliant Blue G Selectively Blocks ATP-Gated Rat P2X7Receptors
Jiang, L.-H., Mackenzie, A. B., North, R. A., & Surprenant, A. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.82 · Cited by 401
Self-citationProteomic and functional evidence for a P2X7 receptor signalling complex
Kim, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6347 · Cited by 379
Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds
Khakh, B. S., Bao, X. R., Labarca, C., & Lester, H. A. (1999) · Nature Neuroscience · doi:10.1038/7233 · Cited by 365
Sorge, R. E., Trang, T., Dorfman, R., Smith, S. B., Beggs, S., Ritchie, J., Austin, J.-S., Zaykin, D. V., Meulen, H. V., Costigan, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2710 · Cited by 359
Purine and Pyrimidine (P2) Receptors as Drug Targets
Jacobson, K. A., Jarvis, M. F., & Williams, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020046y · Cited by 352
Self-citationNeuromodulation by Extracellular ATP and P2X Receptors in the CNS
Khakh, B. S., & North, R. A. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.024 · Cited by 341
Self-citationP2X7 receptor-Pannexin1 complex: pharmacology and signaling
Iglesias, R., Locovei, S., Roque, A., Alberto, A. P., Dahl, G., Spray, D. C., & Scemes, E. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00228.2008 · Cited by 331
The function of microglia through purinergic receptors: Neuropathic pain and cytokine release
Inoue, K. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.001 · Cited by 328
Jarvis, M. F., & Khakh, B. S. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.067 · Cited by 326
Self-citationIvermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor
Krause, R. M., Buisson, B., Bertrand, S., Corringer, P.-J., Galzi, J.-L., Changeux, J.-P., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.2.283 · Cited by 320
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 315
Gever, J. R., Cockayne, D. A., Dillon, M. P., Burnstock, G., & Ford, A. P. D. W. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0070-9 · Cited by 298
Observations on the algogenic actions of adenosine compounds on the human blister base preparation
Bleehen, T., & Keele, C. A. (1977) · Pain · doi:10.1016/0304-3959(77)90066-5 · Cited by 282
Virginio, C., Robertson, G., Surprenant, A., & North, R. A. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13265-8 · Cited by 281
Self-citationAllosteric Control of Gating and Kinetics at P2X4Receptor Channels
Khakh, B. S., Proctor, W. R., Dunwiddie, T. V., Labarca, C., & Lester, H. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07289.1999 · Cited by 279
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
Donnelly‐Roberts, D. L., Namovic, M. T., Han, P., & Jarvis, M. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00233.x · Cited by 271
Self-citationDonnelly‐Roberts, D. L., & Jarvis, M. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707265 · Cited by 266
Self-citationStructural plasticity and dynamic selectivity of acid-sensing ion channel–spider toxin complexes
Baconguis, I., & Gouaux, E. (2012) · Nature · doi:10.1038/nature11375 · Cited by 257
Ideas about pain, a historical view
Perl, E. R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2042 · Cited by 247
Asztély, F., & Gustafsson, B. (1996) · Molecular Neurobiology · doi:10.1007/bf02740744 · Cited by 223
Molecular and functional properties of P2X receptors—recent progress and persisting challenges
Kaczmarek-Hájek, K., Lörinczi, É., Hausmann, R., & Nicke, A. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9314-7 · Cited by 223
P2X7-related modulation of pathological nociception in rats
McGaraughty, S., Chu, K. L., Namovic, M. T., Donnelly-Roberts, D. L., Harris, R. R., Zhang, X.-F., Shieh, C.-C., Wismer, C. T., Zhu, C. Z., Gauvin, D. M., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.035 · Cited by 220
Self-citationHumphreys, B. D., Virginio, C., Surprenant, A., Rice, J., & Dubyak, G. R. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.22 · Cited by 215
Ionotropic Glutamate Receptors & CNS Disorders
Bowie, D. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784083821 · Cited by 202
The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytes
Gargett, C. E., & Wiley, J. S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701081 · Cited by 190
Mechanism of Ivermectin Facilitation of Human P2X4 Receptor Channels
Priel, A., & Silberberg, S. D. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200308986 · Cited by 183
Epithelial Membrane Proteins Induce Membrane Blebbing and Interact with the P2X7 Receptor C Terminus
Wilson, H. L., Wilson, S. A., Surprenant, A., & North, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205120200 · Cited by 181
Self-citationAcute nociception mediated by hindpaw P2X receptor activation in the rat
Bland‐Ward, P. A., & Humphrey, P. P. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701371 · Cited by 181
Donnelly-Roberts, D., McGaraughty, S., Shieh, C.-C., Honore, P., & Jarvis, M. F. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105890 · Cited by 170
Self-citationIn pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization
Ford, A. P. (2012) · Purinergic Signalling · doi:10.1007/s11302-011-9271-6 · Cited by 165
P2Y nucleotide receptors: promise of therapeutic applications
Jacobson, K. A., & Boeynaems, J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.011 · Cited by 148
Antagonists of the P2X7Receptor. From Lead Identification to Drug Development
Guile, S. D., Alcaraz, L., Birkinshaw, T. N., Bowers, K. C., Ebden, M. R., Furber, M., & Stocks, M. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801528x · Cited by 146
Domains of P2X receptors involved in desensitization
Werner, P., Seward, E. P., Buell, G. N., & North, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15485 · Cited by 146
Self-citationThe neural–glial purinergic receptor ensemble in chronic pain states
Jarvis, M. F. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.10.003 · Cited by 142
Self-citationThe Role of the P2X7 Receptor in Infectious Diseases
Miller, C., Boulter, N. R., Fuller, S. J., Zakrzewski, A. M., Lees, M. P., Saunders, B. M., Wiley, J. S., & Smith, N. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002212 · Cited by 141
AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
Gever, J. R., Soto, R., Henningsen, R. A., Martin, R. S., Hackos, D. H., Panicker, S., Rubas, W., Oglesby, I. B., Dillon, M. P., Milla, M. E., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00796.x · Cited by 138
Silberberg, S. D., Li, M., & Swartz, K. J. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.020 · Cited by 133
Honoré, P., Donnelly‐Roberts, D. L., Namovic, M. T., Zhong, C., Wade, C. L., Chandran, P., Zhu, C., Carroll, W. A., Perez‐Medrano, A., Iwakura, Y., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.018 · Cited by 117
Self-citationHernández‐Olmos, V., Abdelrahman, A., El‐Tayeb, A., Diana, F., Weinhausen, S., & Müller, C. E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300845v · Cited by 111
Buttini, M., Mir, A. K., Appel, K., Wiederhold, K.-H., Limonta, S., Gebicke‐Haerter, P. J., & Boddeke, H. W. G. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701502 · Cited by 110
Jarvis, M. F., Wismer, C. T., Schweitzer, E., Yu, H., van Biesen, T., Lynch, K. J., Burgard, E. C., & Kowaluk, E. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703793 · Cited by 106
Self-citationAn Intersubunit Zinc Binding Site in Rat P2X2 Receptors
Nagaya, N., Tittle, R. K., Saar, N., Dellal, S. S., & Hume, R. I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504545200 · Cited by 96
Lewis, C. J., Surprenant, A., & Evans, R. J. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702001 · Cited by 89
Başoğlu, Ö. K., Pelleg, A., Essilfie-Quaye, S., Brindicci, C., Barnes, P. J., & Kharitonov, S. A. (2005) · CHEST Journal · doi:10.1378/chest.128.4.1905 · Cited by 89
Samways, D. S. K., Khakh, B. S., Dutertre, S., & Egan, T. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017550108 · Cited by 88
Airway nerves and dyspnea associated with inflammatory airway disease
Undem, B. J., & Nassenstein, C. (2008) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2008.11.012 · Cited by 87
Allosteric modulation of ATP-gated P2X receptor channels
Coddou, C., Stojilković, S. S., & Huidobro-Toro, J. P. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.014 · Cited by 86
Inhibition of Neuronal Voltage-Gated Sodium Channels by Brilliant Blue G
Jo, S., & Bean, B. P. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070276 · Cited by 85
Tightening of the ATP‐binding sites induces the opening of P2X receptor channels
Jiang, R., Taly, A., Lemoine, D., Martz, A., Cunrath, O., & Grütter, T. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.75 · Cited by 83
Krůšek, J., & Zemkova, H. W. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90500-2 · Cited by 83
Broom, D. C., Matson, D. J., Bradshaw, E., Buck, M. E., Meade, R., Coombs, S. E., Matchett, M., Ford, K. K., Yu, W., Yuan, J., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141853 · Cited by 80
Rettinger, J., Braun, K., Hochmann, H., Kassack, M. U., Ullmann, H., Nickel, P., Schmalzing, G., & Lambrecht, G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.003 · Cited by 72
Involvement of the cysteine-rich head domain in activation and desensitization of the P2X1 receptor
Lörinczi, É., Bhargava, Y., Marino, S. F., Taly, A., Kaczmarek-Hájek, K., Barrantes‐Freer, A., Dutertre, S., Grütter, T., Rettinger, J., & Nicke, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118759109 · Cited by 72
Control of P2X2 Channel Permeability by the Cytosolic Domain
Eickhorst, A. N., Berson, A. E., Cockayne, D. A., Lester, H. A., & Khakh, B. S. (2002) · The Journal of General Physiology · doi:10.1085/jgp.20028535 · Cited by 72
P2X4 purinoceptor signaling in chronic pain
Trang, T., & Salter, M. W. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9306-7 · Cited by 69
Samways, D. S. K., & Egan, T. M. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200609677 · Cited by 68
Jelínková, I., Vávra, V., Jindřichová, M., Obšil, T., Zemkova, H. W., Zemkova, H. W., & Stojilković, S. S. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0450-4 · Cited by 68
P2X receptor antagonists for pain management: examination of binding and physicochemical properties
Gum, R. J., Wakefield, B. D., & Jarvis, M. F. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9272-5 · Cited by 68
Self-citationCalmodulin antagonists depress calcium and potassium currents in ventricular and vascular myocytes
Klöckner, U., & Isenberg, G. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.253.6.h1601 · Cited by 66
Carter, D. S., Alam, M., Cai, H., Dillon, M. P., Ford, A. P. D. W., Gever, J. R., Jahangir, A. M., Lin, C. J., Moore, A. G., Wagner, P. J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.003 · Cited by 65
Ion Channel Drug Discovery: Challenges And Future Directions
Wickenden, A., Priest, B. T., & Erdemli, G. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.4 · Cited by 63
Regulation of P2X2 Receptors by the Neuronal Calcium Sensor VILIP1
Chaumont‐Dubel, S., Compan, V., Toulmé, E., Richler, E., Housley, G. D., Rassendren, F., & Khakh, B. S. (2008) · Science Signaling · doi:10.1126/scisignal.1162329 · Cited by 63
Cao, L., Young, M. T., Broomhead, H. E., Fountain, S. J., & North, R. A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4036-07.2007 · Cited by 63
Self-citationKamei, J., & Takahashi, Y. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.034 · Cited by 54
Fe65 Interacts with P2X2 Subunits at Excitatory Synapses and Modulates Receptor Function
Masin, M., Kerschensteiner, D., Dümke, K., Rubio, M. E., & Soto, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507735200 · Cited by 53
Allsopp, R. C., & Evans, R. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303917 · Cited by 50
(2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.zh0-5879-corr.2009 · Cited by 49
Modification of neuropathic pain sensation through microglial ATP receptors
Inoue, K., Tsuda, M., & Tozaki‐Saitoh, H. (2007) · Purinergic Signalling · doi:10.1007/s11302-007-9071-1 · Cited by 41
Role of Purinergic Receptors in CNS Function and Neuroprotection
Tozaki‐Saitoh, H., Tsuda, M., & Inoue, K. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00015-1 · Cited by 40
Inhibition of olfactory cyclic nucleotide‐activated current by calmodulin antagonists
Kleene, S. J. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14760.x · Cited by 36
Ballini, E., Virginio, C., Medhurst, S., Summerfield, S. G., Aldegheri, L., Buson, A., Carignani, C., Chen, Y., Giacometti, A., Lago, I., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01322.x · Cited by 33
Discovery of P2X3 selective antagonists for the treatment of chronic pain
Cantin, L., Bayrakdarian, M., Buon, C., Grazzini, E., Hu, Y., Labrecque, J., Leung, C. O. N., Luo, X., Martino, G., Paré, M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.124 · Cited by 33
Ziyal, R., Зиганшин, А. У., Nickel, P., Ardanuy, U., Mutschler, E., Lambrecht, G., & Burnstock, G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700984 · Cited by 29
Blockade of P2X‐purinoceptors by trypan blue in rat vas deferens
Bültmann, R., Trendelenburg, M., & Starke, K. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb16994.x · Cited by 25
Purinergic Signalling between Axons and Microglia
Virgilio, F. D. (2006) · Novartis Foundation symposium · doi:10.1002/9780470032244.ch20 · Cited by 19
Themed section: molecular pharmacology of GPCRs
Summers, R. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01679.x · Cited by 5
Cited by
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 902
Big opportunities for small molecules in immuno-oncology
Adams, J. L., Smothers, J., Srinivasan, R., & Hoos, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4596 · Cited by 471
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00052 · Cited by 437
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390
The P2X7 receptor: A main player in inflammation
Adinolfi, E., Giuliani, A. L., De Marchi, E., Pegoraro, A., Orioli, E., & Di Virgilio, F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.021 · Cited by 385
Metadata
- Authors
- North, R. A., & Jarvis, M. F.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 83
- Issue
- 4
- Pages
- 759-769
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2144195410
- Cited by
- 270
- References
- 102
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.